It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Japan drugmaker Shionogi to seek approval for oral COVID-19 drug

National Aug 6, 2021

Japan drugmaker Shionogi to seek approval for oral COVID-19 drug

Designed to prevent moderate COVID-19 symptoms from worsening, the drug could facilitate at-home treatment and ease the strain on hospitals.

Why vaccination should be compulsory

Commentary / World Aug 5, 2021

Why vaccination should be compulsory

by Peter Singer

Laws requiring people to be vaccinated may be restricting one kind of freedom, but they are doing so in order to protect the freedom of others to go about their business safely.

SoftBank built a $5 billion stake in pharma giant Roche

Business / Corporate Aug 4, 2021

SoftBank built a $5 billion stake in pharma giant Roche

by Giles Turner and Tom Giles

Roche's diagnostics unit reacted swiftly to the pandemic, and now sales are boosted by its COVID-19 testing business.

More shots alone won’t win the global war on variants

Commentary / World Aug 2, 2021

More shots alone won’t win the global war on variants

The delta COVID-19 variant is tipping the pandemic into a frightening new stage and vaccination efforts are unable to keep up.

Legitimate pain research is more crucial than ever

Commentary / World Jul 30, 2021

Legitimate pain research is more crucial than ever

by Faye Flam

Researchers today say opioids are not only dangerous; they are not a good long-term solution for chronic pain sufferers. The relief tends to wane with time.

Even with delta surging, experts say two vaccine doses is enough for now

National Jul 29, 2021

Even with delta surging, experts say two vaccine doses is enough for now

by Osamu Tsukimori

U.S. firm Pfizer Inc. has called for an additional third shot of its COVID-19 vaccine, citing new data showing its efficacy tails off after six months.

How behavioral economics views mask mandates

Commentary / World Jul 29, 2021

How behavioral economics views mask mandates

by Allison Schrager

What we know from behavioral economics suggests that universal mask requirements will undermine the effort to get as many people as possible vaccinated.

Doctors blast Biogen Alzheimer approval as ‘regulatory failure’

World / Science & Health Jul 29, 2021

Doctors blast Biogen Alzheimer approval as ‘regulatory failure’

by Robert Langreth

The New England Journal of Medicine opinion piece is another sign of persistent furor over the agency’s decision.

London’s delta surge should jolt New York

Commentary / World Jul 26, 2021

London’s delta surge should jolt New York

by Max Nisen

A big question is whether New York, another large city that has reopened after having been through the COVID-19 wringer in 2020, will face a similar resurgence of cases like London.

At this point, the U.K.'s COVID-19 rules follow politics as much as science

Commentary / World Jul 22, 2021

At this point, the U.K.'s COVID-19 rules follow politics as much as science

by Therese Raphael

If the last 18 months have taught us anything, it’s that a successful COVID-19 policy requires three things: high levels of public trust, a coherent strategy and effective implementation.

As delta variant rages in Southeast Asia, health workers warned not to speak out

Commentary / World Jul 21, 2021

As delta variant rages in Southeast Asia, health workers warned not to speak out

by Alifah Zainuddin

In Southeast Asian nations, health care providers calling for stronger job security and better protection against variants of the coronavirus, have put governments on the defensive.

World carved up into haves and have-nots by mRNA vaccine access

World | FOCUS Jul 16, 2021

World carved up into haves and have-nots by mRNA vaccine access

by Bruce Einhorn

The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus.

« 1 … 27 28 29 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times